Title:
ADMINISTRATION SCHEME FOR THROMBOPOIETIN RECEPTOR AGONIST
Document Type and Number:
WIPO Patent Application WO/2022/228551
Kind Code:
A1
Abstract:
The present disclosure relates to an administration scheme for a thrombopoietin receptor agonist. Specifically, provided in the present disclosure is a method for treating thrombocytopenia, comprising administering to a patient a therapeutically effective amount of a compound as represented by formula I or a pharmaceutically acceptable salt thereof, wherein the compound as represented by formula I or the pharmaceutically acceptable salt thereof, which is administered to the patient, does not have a drug-drug interaction with a BCRP substrate in the patient.
Inventors:
LIN HONGDA (CN)
SHEN KAI (CN)
DING XUEYING (CN)
QU WENJUN (CN)
SHEN KAI (CN)
DING XUEYING (CN)
QU WENJUN (CN)
Application Number:
PCT/CN2022/090302
Publication Date:
November 03, 2022
Filing Date:
April 29, 2022
Export Citation:
Assignee:
JIANGSU HENGRUI PHARMACEUTICALS CO LTD (CN)
International Classes:
A61P7/04; A61K31/4155; A61K31/655; A61P7/00; A61P7/02; C07D405/12
Domestic Patent References:
| WO2020143593A1 | 2020-07-16 | |||
| WO2009092276A1 | 2009-07-30 | |||
| WO2010142137A1 | 2010-12-16 |
Foreign References:
| CN104844582A | 2015-08-19 | |||
| CN110028497A | 2019-07-19 | |||
| US5260440A | 1993-11-09 | |||
| CN1333756A | 2002-01-30 | |||
| CN105153040A | 2015-12-16 |
Attorney, Agent or Firm:
SHANGHAI BESHINING LAW OFFICE (CN)
Download PDF:
Previous Patent: SUPERCONDUCTING QUANTUM CHIP
Next Patent: SYNCHRONIZATION SIGNAL BLOCK PERIODICITY CHANGES
Next Patent: SYNCHRONIZATION SIGNAL BLOCK PERIODICITY CHANGES